Why the study?
The study was conducted to explore the prevalence and risk factors of NAFLD and MAFLD in patients with polycystic ovary syndrome.
Is the prevalence of NAFLD and MAFLD higher in women with PCOS compared to healthy controls, and what are the associated risk factors?
Population
217 PCOS patients and 72 healthy controls across 6 centers in China
Comparison
PCOS patients vs age-matched healthy controls
Design
Multi-center cross-sectional study
Authors
Loading...
NAFLD/MAFLD prevalence is higher in PCOS and tied to IR/ALT/overweight; leaves open causal inference and need for longitudinal outcome studies.
Is the prevalence of NAFLD and MAFLD higher in women with PCOS compared to healthy controls, and what are the associated risk factors?
Women with PCOS have a significantly higher prevalence of NAFLD and MAFLD compared to healthy controls, which is independently associated with insulin resistance and elevated ALT.
Hong et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: